No title
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphomas in terms of molecular profile and clinical outcomes, highlighting the need to identify new biomarkers to stratify patients. In this thesis, the protein expression of BCL2, PLK1, MYC and p53 was evaluated in a DLBCL-cohort using multiplex immunofluorescence (mIF) to investigate correlations between protein expression and su
